Khalil El Gharib (K El Gharib)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Emergency Department

Respiratory Syndrome Coronavirus

Muscle Invasive Bladder Cancer

Radical Prostatectomy

Top Venues

Expert review of anticancer therapy

Future oncology (London, England)

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Eddy Lilly, Julien Sarkis, Omar Mahmoud, Khalil El Gharib, Pierre Sarkis, Elie Nemr
Novel breakthroughs in advanced prostate cancer management. Expert review of anticancer therapy (2023)
Khalil El Gharib, Marc Assaad, Michel Chalhoub
Diaphragmatic ultrasound in weaning ventilated patients: a reliable predictor? Expert review of respiratory medicine 16 (8) (2022)
Khalil El Gharib, Makram Khoury, Hampig Raphaël Kourie
HER2 in gastric adenocarcinoma: where do we stand today? Personalized medicine (2021)
Khalil El Gharib, Eddy Lilly, Roy Chebel
Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder? Immunotherapy 13 (13) (2021)
Eddy Lilly, Khalil El Gharib
Immunotherapy and non-muscle-invasive bladder cancer: an idea from the 19th century. Expert review of anticancer therapy 21 (7) (2021)
P Sarkis, Julien Sarkis, Marwan Alkassis, Joy Assaf, Khalil El Gharib
Penile ischaemia secondary to COVID-19: why should the dermatologist be concerned? Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Khalil El Gharib, Hampig Raphaël Kourie
NTRK genes and cancer: when arresting the fusion underlies the treatment. Epigenomics 13 (8) (2021)
Khalil El Gharib, Hampig Raphaël Kourie
Is ramucirumab still the only second-line treatment in metastatic gastric cancer? Pharmacogenomics 21 (17) (2020)
Khalil El Gharib
Adjuvant therapy in renal cell carcinoma: is resection still solely enough? Future oncology (London, England) 17 (6) (2020)
Khalil El Gharib
The sinoatrial node in medication-resistant inappropriate sinus tachycardia: To modify or to ablate? Journal of cardiovascular electrophysiology 32 (1) (2020)